Company: DVAX
Filing Date: 2025-01-13
Form Type: 8-K
Source: 0001029142-25-000003
Chunk: 2

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-01-13
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are furnished herewith:

  99.1      Press release dated January 13, 202 5 titled " Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights. "  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  99.2      Dynavax Investor Presentation.                                                                                                                    
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                       

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                            Dynavax Technologies Corporation  
  Date:      January 13, 2025      By:      /s/ Kelly MacDonald               
                                            Kelly MacDonald